Vogt-Koyanagi-Harada disease

Current Opinion in Ophthalmology

Volumn 11, Issue 6, 2000, Pages 437-442

  Read, Russell W ^a   Rao, Narsing A ^b   Cunningham Jr , Emmett T ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOSTEROID SPARING AGENT; MONOPHENOL MONOOXYGENASE; TYROSINASE RELATED PROTEIN; UNCLASSIFIED DRUG;

ANGIOGRAPHY; ANTIGENICITY; ARTICLE; AUTOIMMUNE DISEASE; CHOROID; DOSE RESPONSE; FIBROSIS; HUMAN; MELANOCYTE; NEOVASCULARIZATION (PATHOLOGY); NEUROOPHTHALMOLOGY; NUCLEAR MAGNETIC RESONANCE; PATHOGENESIS; PRIORITY JOURNAL; RACE DIFFERENCE; VISUAL IMPAIRMENT; VOGT KOYANAGI SYNDROME;

AUTOIMMUNITY; BLINDNESS; CHOROIDAL NEOVASCULARIZATION; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; GLUCOCORTICOIDS; HUMANS; MAGNETIC RESONANCE IMAGING; MELANOCYTES; MEMBRANE GLYCOPROTEINS; MONOPHENOL MONOOXYGENASE; OXIDOREDUCTASES; PROGNOSIS; PROTEINS; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 0033674643     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200012000-00009     Document Type: Article

References (57)

1. Mechanisms of inflammatory response in sympathetic ophthalmia VKH syndrome
2. Vogt-Koyanagi-Harada syndrome in patients with Cherokee Indian ancestry
3. Vogt-Koyanagi-Harada syndrome
4. Vogt-Koyanagi-Harada syndrome in a 4-year-old child
5. Vogt-Koyanagi-Harada syndrome in children compared to adults
6. Vogt-Koyanagi-Harada syndrome in children
7. Headache bilateral visual loss in a young hypothyroid Indian man
8. Eye disease in a patient with rheumatoid arthritis
9. The Vogt-Koyanagi-Harada syndrome: Association with autoimmune polyglandular syndrome type 1
10. Vogt-Koyanagi-Harada disease in identical twins
11. Vogt-Koyanagi-Harada disease in monozygotic twins
12. Simultaneous onset of Vogt-Koyanagi-Harada syndrome in monozygotic twins
13. Intrafamilial occurrence of tubulointerstitial nephritis with uveitis Vogt-Koyanagi-Harada syndrome
14. Vogt-Koyanagi-Harada disease: Extensive vitiligo with prodromal generalized erythroderma
15. High incidence of glucose intolerance in Vogt-Koyanagi-Harada disease
16. Class II major histocompatibility complex on melanocytes of Vogt-Koyanagi-Harada disease
17. Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus
18. Vitiligo in Vogt-Koyanagi-Harada disease: Immunohistological analysis of inflammatory site
19. Complete association of the HLA-DRB1*04 and -DQB1*04 alleles with Vogt-Koyanagi-Harada's disease
20. Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California
21. Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans
22. Vogt-Koyanagi-Harada disease and HLA type in Italian patients
23. HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients
24. Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population
25. HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease
26. Vogt-Koyanagi-Harada syndrome in patients of Vietnamese ancestry
27. HLA-DRB1*0405 and presentation of peptides derived from human melanocyte/melanoma proteins in Vogt-Koyanagi-Harada disease
28. Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient
29. Identification of specific antigen for Vogt-Koyanagi-Harada disease: Lymphocyte reactivity against the tyrosinase family proteins
30. Establishment and analysis of T cell clones from VKH disease patients
31. Experimental Vogt-Koyanagi-Harada disease induced in pigmented rats
32. Ocular histopathology of Vogt-Koyanagi-Harada-like syndrome in an Akita dog
33. Detection of Epstein-Barr virus DNA by polymerase chain reaction in the vitreous from a patient with Vogt-Koyanagi-Harada syndrome
34. High inducibility of Epstein-Barr virus replication in B lymphocytes in Vogt-Koyanagi-Harada disease
35. Vogt-Koyanagi-Harada syndrome after cutaneous injury
36. Echographic features of the Vogt-Koyanagi-Harada syndrome
37. Vogt-Koyanagi-Harada syndrome
38. Utility of existing Vogt-Koyanagi-Harada syndrome diagnostic criteria at initial evaluation of the individual patient: A retrospective analysis
39. Subtraction ICG angiography in Harada's disease
40. Exploration of Vogt-Koyanagi-Harada syndrome by infrared choroidal angiography with indocyanine green
41. Videofunduscopy and videoangiography using the scanning laser ophthalmoscope in Vogt-Koyanagi-Harada syndrome
42. Schematic interpretation of indocyanine green angiography in posterior uveitis using a standard angiographic protocol
43. Indocyanine green angiography in posterior uveitis
44. Quantitative evaluation of 'sunset glow' fundus in Vogt-Koyanagi-Harada disease
45. The syndrome of Vogt-Koyanagi-Harada and pregnancy
46. Vogt-Koyanagi-Harada disease during pregnancy
47. Vogt-Koyanagi-Harada syndrome and pregnancy
48. Vogt-Koyanagi-Harada syndrome in a pregnant patient treated with high-dose systemic corticosteroids
49. Complications and prognostic factors in Vogt-Koyanagi-Harada syndrome
50. Extensive chorioretinal atrophy in Vogt-Koyanagi-Harada disease
51. Subretinal fibrosis in patients with Vogt-Koyanagi-Harada syndrome
52. Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome
53. Subretinal neovascular membranes in Vogt-Koyanagi-Harada syndrome
54. Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis
55. Cyclosporine-induced resolution of choroidal neovascularization associated with sympathetic ophthalmia
56. The use of corticosteroids for choroidal neovascularisation in young patients
57. Surgical removal of subfoveal choroidal neovascular membranes in Vogt-Koyanagi-Harada syndrome: Clinical and histopathological results